MedPath

Effect of a cognitive bias modification of interpretations on anxiety and depressive symptoms in adults

Not Applicable
Conditions
Anxiety
Depression
Mental Health - Anxiety
Mental Health - Depression
Registration Number
ACTRN12620000680965
Lead Sponsor
Dr Gemma Sicouri
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
All
Target Recruitment
59
Inclusion Criteria

Prior to taking part in the study, individuals will be screened for elevated levels of anxiety and depression symptoms. This is because the study involves training to reduce anxiety and depression symptoms and screening will reduce the likelihood of a floor effect of the training. Only participants who self-report as having mild (or above) levels of anxiety and depressive symptoms using a validated self-report questionnaire of anxiety and depression symptoms (Kessler Psychological Distress Scale K10] (Kessler et al., 2003)) will be invited to take part. Only individuals who meet this eligibility criteria, who are aged 18 years and above and fluent in English will be invited to participate in the study.

Exclusion Criteria

Those in current treatment for an anxiety- or depression- related mental health condition.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Interpretation bias scores will be measured on the Interpretation Bias Task (IBT) measure, at pre-training, post-training, and 1-week follow-up.[Pre training (immediately prior to training session), post training (immediately after training session) and 1-week follow-up. Primary time-point is post-training measurement.];Attribution style scores will be measured on the Attribution Style Questionnaire (ASQ) measure, at pre-training, post-training, and 1-week follow-up.[Pre training (immediately prior to training session), post training (immediately after training session) and 1-week follow-up. Primary time-point is post-training measurement.]
Secondary Outcome Measures
NameTimeMethod
Depression, anxiety and stress scores will be measured on the DASS-21 at pre-training (immediately prior to training session) and 1-week follow-up.[Pre training (immediately prior to training session), 1-week follow-up.];Depression and tension scores will be measured on the POMS-SF depression and tension sub-scales at pre-training (immediately prior to training session) and post-training (immediately after training session).[Pre training (immediately prior to training session), post training (immediately after training session).];Score on Acceptability of Treatment Scale (ATS) will be measured.[1-week follow-up]
© Copyright 2025. All Rights Reserved by MedPath